Relationship Between Grip Endurance, Disability of Upper Extremity and Quality of Life in Patients With RA

September 23, 2020 updated by: Melissa Köprülüoğlu, Izmir Katip Celebi University

Investigation of the Relationship Between Grip Endurance, Disability of Upper Extremity and Quality of Life in Patients With Rheumatoid Arthritis

The aim of this study is to investigate the relationship between grip endurance, disability of upper extremity and quality of life in patients with rheumatoid arthritis.

Study Overview

Status

Completed

Detailed Description

Upper extremity functions affect the quality of life at different levels in patients with rheumatoid arthritis (RA). In the current literature; it has been shown that grip endurance is associated with upper limb functions. However, there is no study investigating the relationship between grip endurance and quality of life in patients with RA. The purpose of this study is to investigate the relationship between grip endurance, disability of upper extremity, and quality of life in patients with RA.

Study Type

Observational

Enrollment (Actual)

23

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Izmir/ Cigli
      • Izmir, Izmir/ Cigli, Turkey
        • Izmir Katip Celebi University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The population of the study consists of RA patients.

Description

Inclusion Criteria:

  • RA patients were classified according to the ACR 2010 criteria.
  • taking regular medication.

Exclusion Criteria:

  • having a history of trauma or surgery in the upper limb.
  • having neurological, cognitive, or psychiatric diseases.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Static Grip Endurance
Time Frame: Data collection will continue until December 2019. Data analysis and report preparation will be completed by September 2020.
Static grip endurance was evaluated by Hand Dynamometer (Lafayette Proffessional Hand Dynamometer, USA). The maximum gripping time of 50% of the maximum grip force was recorded.
Data collection will continue until December 2019. Data analysis and report preparation will be completed by September 2020.
Dynamic Grip Endurance
Time Frame: Data collection will continue until December 2019. Data analysis and report preparation will be completed by September 2020.
Dynamic grip endurance was evaluated by Hand Dynamometer (Lafayette Proffessional Hand Dynamometer, USA). The percentage change between the first 3 grips and the last 3 grips after 10 consecutive grips is recorded.
Data collection will continue until December 2019. Data analysis and report preparation will be completed by September 2020.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Disability of Upper Extremity
Time Frame: Data collection will continue until December 2019. Data analysis and report preparation will be completed by September 2020.
This parameter was evaluated by Disability of Arm, Shoulder and Hand (DASH) questionairre.
Data collection will continue until December 2019. Data analysis and report preparation will be completed by September 2020.
Quality of Life Parameters
Time Frame: Data collection will continue until December 2019. Data analysis and report preparation will be completed by September 2020.
This parameter was evaluated by Short Form-36.
Data collection will continue until December 2019. Data analysis and report preparation will be completed by September 2020.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Melissa KÖPRÜLÜOĞLU, İzmir Katip Celebi University, Faculty of Health Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 1, 2019

Primary Completion (ACTUAL)

April 1, 2020

Study Completion (ACTUAL)

September 10, 2020

Study Registration Dates

First Submitted

September 23, 2020

First Submitted That Met QC Criteria

September 23, 2020

First Posted (ACTUAL)

September 24, 2020

Study Record Updates

Last Update Posted (ACTUAL)

September 24, 2020

Last Update Submitted That Met QC Criteria

September 23, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rheumatoid Arthritis

Subscribe